CATALAYER NEWS
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease - Reuters
Source: Reuters · 2026-01-13
Full article text is available in the Catalayer news terminal.
MORE FROM REUTERS
IBM to invest $10 billion for large-scale quantum computer by 2029
2026-05-29
Exclusive-China works on AI token futures market, sources say, in race with US
2026-05-29
From diapers to drugs: How India's global corporate hubs are putting AI to work
2026-05-29
Inflation challenges US Treasuries' traditional role in portfolios
2026-05-29
US judge orders removal of Trump's name from Kennedy Center - Reuters
2026-05-29
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets